Cargando…

VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis

Introduction: Rheumatoid arthritis (RA) is an important public health problem because this disease often causes disability. RA is a chronic, destructive autoimmune disease that leads to joint destruction and the development of extraarticular manifestations. VAV1 is an intracellular signal transducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlik, Andrzej, Malinowski, Damian, Paradowska-Gorycka, Agnieszka, Safranow, Krzysztof, Dziedziejko, Violetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246862/
https://www.ncbi.nlm.nih.gov/pubmed/32380774
http://dx.doi.org/10.3390/ijerph17093214
_version_ 1783538045949050880
author Pawlik, Andrzej
Malinowski, Damian
Paradowska-Gorycka, Agnieszka
Safranow, Krzysztof
Dziedziejko, Violetta
author_facet Pawlik, Andrzej
Malinowski, Damian
Paradowska-Gorycka, Agnieszka
Safranow, Krzysztof
Dziedziejko, Violetta
author_sort Pawlik, Andrzej
collection PubMed
description Introduction: Rheumatoid arthritis (RA) is an important public health problem because this disease often causes disability. RA is a chronic, destructive autoimmune disease that leads to joint destruction and the development of extraarticular manifestations. VAV1 is an intracellular signal transduction protein that plays a significant role in signal transduction in T cells and affects T cell development, proliferation and activation. The VAV1 gene contains 27 exons and is located on chromosome 19. In this study, we examined the association between VAV1 rs2546133 and rs2617822 polymorphisms and RA. Methods: We examined 422 patients with RA and 338 healthy subjects as the control group. Results: Among RA patients, there was a statistically significant increase in the frequency of VAV1 rs2546133 polymorphism in T allele carriers (TT + CT versus CC, odds ratio: 1.69, 95% confidence interval 1.05–2.73, p = 0.035). There was no statistically significant difference in the distribution of the rs2617822 genotypes and alleles between RA patients and the control group. Additionally, patients who carried the VAV1 rs2546133 T and rs2617822 G allele presented an increased frequency of extraarticular manifestations: vasculitis, amyloidosis and Sjogren syndrome. Conclusions: The results suggest an association between VAV1 gene rs2617822 polymorphism and RA.
format Online
Article
Text
id pubmed-7246862
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72468622020-06-02 VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis Pawlik, Andrzej Malinowski, Damian Paradowska-Gorycka, Agnieszka Safranow, Krzysztof Dziedziejko, Violetta Int J Environ Res Public Health Article Introduction: Rheumatoid arthritis (RA) is an important public health problem because this disease often causes disability. RA is a chronic, destructive autoimmune disease that leads to joint destruction and the development of extraarticular manifestations. VAV1 is an intracellular signal transduction protein that plays a significant role in signal transduction in T cells and affects T cell development, proliferation and activation. The VAV1 gene contains 27 exons and is located on chromosome 19. In this study, we examined the association between VAV1 rs2546133 and rs2617822 polymorphisms and RA. Methods: We examined 422 patients with RA and 338 healthy subjects as the control group. Results: Among RA patients, there was a statistically significant increase in the frequency of VAV1 rs2546133 polymorphism in T allele carriers (TT + CT versus CC, odds ratio: 1.69, 95% confidence interval 1.05–2.73, p = 0.035). There was no statistically significant difference in the distribution of the rs2617822 genotypes and alleles between RA patients and the control group. Additionally, patients who carried the VAV1 rs2546133 T and rs2617822 G allele presented an increased frequency of extraarticular manifestations: vasculitis, amyloidosis and Sjogren syndrome. Conclusions: The results suggest an association between VAV1 gene rs2617822 polymorphism and RA. MDPI 2020-05-05 2020-05 /pmc/articles/PMC7246862/ /pubmed/32380774 http://dx.doi.org/10.3390/ijerph17093214 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pawlik, Andrzej
Malinowski, Damian
Paradowska-Gorycka, Agnieszka
Safranow, Krzysztof
Dziedziejko, Violetta
VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis
title VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis
title_full VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis
title_fullStr VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis
title_full_unstemmed VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis
title_short VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis
title_sort vav1 gene polymorphisms in patients with rheumatoid arthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246862/
https://www.ncbi.nlm.nih.gov/pubmed/32380774
http://dx.doi.org/10.3390/ijerph17093214
work_keys_str_mv AT pawlikandrzej vav1genepolymorphismsinpatientswithrheumatoidarthritis
AT malinowskidamian vav1genepolymorphismsinpatientswithrheumatoidarthritis
AT paradowskagoryckaagnieszka vav1genepolymorphismsinpatientswithrheumatoidarthritis
AT safranowkrzysztof vav1genepolymorphismsinpatientswithrheumatoidarthritis
AT dziedziejkovioletta vav1genepolymorphismsinpatientswithrheumatoidarthritis